Zejula 100 mg

Zejula 100 mg is a medicine authorised by Swissmedic under authorisation number 68652. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 January 2023 and the authorisation is limited until 19 January 2028. ATC code L01XK02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68652
  • ATC L01XK02
  • Synthetic medicines
Authorisation data
Authorisation number68652
NameZejula 100 mg
Full nameZejula 100 mg, Filmtabletten
Authorisation holderGlaxoSmithKline AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XK02
First authorisation20 January 2023
Authorisation validity19 January 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Zejula 100 mg, FilmtablettenA20 January 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)L01XK0207.16.1.A
284Tablette(n)L01XK0207.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Zejula 100 mg authorised in Switzerland?

Yes. Zejula 100 mg is authorised by Swissmedic under authorisation number 68652, data as of 01 September 2026. The authorisation is limited until 19 January 2028.

Which dispensing category does Zejula 100 mg have?

Zejula 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Zejula 100 mg?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com